Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(3.64)
# 884
Out of 4,479 analysts
149
Total ratings
28.57%
Success rate
12.36%
Average return
Main Sectors:
39 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SAVA Cassava Sciences | Downgrades: Neutral | n/a | $12.14 | - | 13 | Jul 1, 2024 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $4.39 | +378.36% | 9 | Jun 28, 2024 | |
| AEMD Aethlon Medical | Maintains: Buy | $10 → $7 | $0.45 | +1,455.56% | 5 | Jun 24, 2024 | |
| GOVX GeoVax Labs | Maintains: Buy | $8 → $120 | $3.28 | +3,558.54% | 10 | Jun 18, 2024 | |
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $2.00 | +350.00% | 4 | Jun 14, 2024 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $5 | $1.35 | +270.37% | 7 | Jun 5, 2024 | |
| ELDN Eledon Pharmaceuticals | Reiterates: Buy | $16 | $2.51 | +537.45% | 8 | Jun 4, 2024 | |
| CTXR Citius Pharmaceuticals | Reiterates: Buy | $4 | $0.54 | +636.24% | 8 | May 31, 2024 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $0.67 | +495.50% | 5 | May 14, 2024 | |
| NVAX Novavax | Reiterates: Buy | $19 | $12.73 | +49.25% | 16 | May 13, 2024 | |
| CANF Can-Fite BioPharma | Reiterates: Buy | $18 | $2.61 | +589.66% | 4 | May 9, 2024 | |
| SENS Senseonics Holdings | Reiterates: Buy | $2 | $0.40 | +405.31% | 6 | Mar 11, 2024 | |
| ENVB Enveric Biosciences | Initiates: Buy | $10 | $0.58 | +1,614.09% | 1 | Jan 30, 2024 | |
| WINT Windtree Therapeutics | Initiates: Neutral | $18 | $3.20 | +462.50% | 1 | Jan 3, 2024 | |
| MBRX Moleculin Biotech | Initiates: Buy | $45 | $3.45 | +1,204.35% | 1 | Dec 14, 2023 | |
| HUMA Humacyte | Initiates: Buy | $6 | $5.37 | +11.73% | 1 | Dec 11, 2023 | |
| CADL Candel Therapeutics | Reiterates: Buy | $11 | $6.30 | +74.60% | 3 | Nov 13, 2023 | |
| DYAI Dyadic International | Reiterates: Buy | $6 | $1.53 | +292.16% | 5 | Nov 13, 2023 | |
| ARDS Aridis Pharmaceuticals | Reiterates: Buy | $2 | $0.06 | +3,233.33% | 6 | Nov 6, 2023 | |
| AYTU Aytu BioPharma | Reiterates: Buy | $20 | $2.85 | +601.75% | 4 | May 31, 2023 | |
| TFFP TFF Pharmaceuticals | Maintains: Buy | $550 → $100 | $1.78 | +5,517.98% | 2 | May 25, 2023 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $20 | $2.58 | +675.19% | 3 | May 25, 2023 | |
| FNCH Finch Therapeutics Group | Reiterates: Buy | $210 | $1.22 | +17,113.11% | 3 | May 12, 2023 | |
| NDRA ENDRA Life Sciences | Reiterates: Buy | $100 → $9 | $0.09 | +9,598.28% | 2 | Mar 31, 2023 | |
| MCRB Seres Therapeutics | Reiterates: Buy | $25 | $0.72 | +3,362.60% | 5 | Mar 8, 2023 | |
| VTVT vTv Therapeutics | Reiterates: Buy | $240 | $17.59 | +1,264.80% | 4 | Mar 7, 2023 | |
| APM Aptorum Group | Initiates: Buy | $80 | $4.07 | +1,865.80% | 1 | Oct 7, 2022 | |
| POAI Predictive Oncology | Initiates: Buy | n/a | $1.03 | - | 1 | Jun 30, 2021 | |
| TENX Tenax Therapeutics | Initiates: Buy | $8,000 | $3.00 | +266,566.67% | 1 | Dec 29, 2020 | |
| GERN Geron | Maintains: Buy | n/a | $4.34 | - | 1 | Aug 26, 2020 | |
| NSPR InspireMD | Reiterates: Buy | n/a | $2.44 | - | 1 | Mar 11, 2020 | |
| NAVB Navidea Biopharmaceuticals | Reiterates: Buy | n/a | $0.00 | - | 1 | Mar 2, 2020 | |
| ACHV Achieve Life Sciences | Initiates: Buy | n/a | $4.78 | - | 1 | Feb 25, 2020 | |
| CVM CEL-SCI | Initiates: Buy | n/a | $1.13 | - | 1 | Jan 13, 2020 | |
| GALT Galectin Therapeutics | Initiates: Buy | n/a | $2.35 | - | 1 | Oct 6, 2017 | |
| EVOK Evoke Pharma | Initiates: Buy | n/a | $0.47 | - | 1 | Oct 6, 2017 | |
| CYTK Cytokinetics | Initiates: Buy | n/a | $54.70 | - | 1 | Oct 6, 2017 | |
| GLMD Galmed Pharmaceuticals | Initiates: Buy | n/a | $0.28 | - | 1 | Oct 6, 2017 | |
| RDHL RedHill Biopharma | Initiates: Buy | n/a | $0.36 | - | 1 | Oct 6, 2017 |
Cassava Sciences
Jul 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $12.14
Upside: -
Edesa Biotech
Jun 28, 2024
Reiterates: Buy
Price Target: $21
Current: $4.39
Upside: +378.36%
Aethlon Medical
Jun 24, 2024
Maintains: Buy
Price Target: $10 → $7
Current: $0.45
Upside: +1,455.56%
GeoVax Labs
Jun 18, 2024
Maintains: Buy
Price Target: $8 → $120
Current: $3.28
Upside: +3,558.54%
Cardiol Therapeutics
Jun 14, 2024
Reiterates: Buy
Price Target: $9
Current: $2.00
Upside: +350.00%
Artelo Biosciences
Jun 5, 2024
Reiterates: Buy
Price Target: $5
Current: $1.35
Upside: +270.37%
Eledon Pharmaceuticals
Jun 4, 2024
Reiterates: Buy
Price Target: $16
Current: $2.51
Upside: +537.45%
Citius Pharmaceuticals
May 31, 2024
Reiterates: Buy
Price Target: $4
Current: $0.54
Upside: +636.24%
Phio Pharmaceuticals
May 14, 2024
Reiterates: Buy
Price Target: $4
Current: $0.67
Upside: +495.50%
Novavax
May 13, 2024
Reiterates: Buy
Price Target: $19
Current: $12.73
Upside: +49.25%
Can-Fite BioPharma
May 9, 2024
Reiterates: Buy
Price Target: $18
Current: $2.61
Upside: +589.66%
Senseonics Holdings
Mar 11, 2024
Reiterates: Buy
Price Target: $2
Current: $0.40
Upside: +405.31%
Enveric Biosciences
Jan 30, 2024
Initiates: Buy
Price Target: $10
Current: $0.58
Upside: +1,614.09%
Windtree Therapeutics
Jan 3, 2024
Initiates: Neutral
Price Target: $18
Current: $3.20
Upside: +462.50%
Moleculin Biotech
Dec 14, 2023
Initiates: Buy
Price Target: $45
Current: $3.45
Upside: +1,204.35%
Humacyte
Dec 11, 2023
Initiates: Buy
Price Target: $6
Current: $5.37
Upside: +11.73%
Candel Therapeutics
Nov 13, 2023
Reiterates: Buy
Price Target: $11
Current: $6.30
Upside: +74.60%
Dyadic International
Nov 13, 2023
Reiterates: Buy
Price Target: $6
Current: $1.53
Upside: +292.16%
Aridis Pharmaceuticals
Nov 6, 2023
Reiterates: Buy
Price Target: $2
Current: $0.06
Upside: +3,233.33%
Aytu BioPharma
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.85
Upside: +601.75%
TFF Pharmaceuticals
May 25, 2023
Maintains: Buy
Price Target: $550 → $100
Current: $1.78
Upside: +5,517.98%
NRx Pharmaceuticals
May 25, 2023
Reiterates: Buy
Price Target: $20
Current: $2.58
Upside: +675.19%
Finch Therapeutics Group
May 12, 2023
Reiterates: Buy
Price Target: $210
Current: $1.22
Upside: +17,113.11%
ENDRA Life Sciences
Mar 31, 2023
Reiterates: Buy
Price Target: $100 → $9
Current: $0.09
Upside: +9,598.28%
Seres Therapeutics
Mar 8, 2023
Reiterates: Buy
Price Target: $25
Current: $0.72
Upside: +3,362.60%
vTv Therapeutics
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $17.59
Upside: +1,264.80%
Aptorum Group
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $4.07
Upside: +1,865.80%
Predictive Oncology
Jun 30, 2021
Initiates: Buy
Price Target: n/a
Current: $1.03
Upside: -
Tenax Therapeutics
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $3.00
Upside: +266,566.67%
Geron
Aug 26, 2020
Maintains: Buy
Price Target: n/a
Current: $4.34
Upside: -
InspireMD
Mar 11, 2020
Reiterates: Buy
Price Target: n/a
Current: $2.44
Upside: -
Navidea Biopharmaceuticals
Mar 2, 2020
Reiterates: Buy
Price Target: n/a
Current: $0.00
Upside: -
Achieve Life Sciences
Feb 25, 2020
Initiates: Buy
Price Target: n/a
Current: $4.78
Upside: -
CEL-SCI
Jan 13, 2020
Initiates: Buy
Price Target: n/a
Current: $1.13
Upside: -
Galectin Therapeutics
Oct 6, 2017
Initiates: Buy
Price Target: n/a
Current: $2.35
Upside: -
Evoke Pharma
Oct 6, 2017
Initiates: Buy
Price Target: n/a
Current: $0.47
Upside: -
Cytokinetics
Oct 6, 2017
Initiates: Buy
Price Target: n/a
Current: $54.70
Upside: -
Galmed Pharmaceuticals
Oct 6, 2017
Initiates: Buy
Price Target: n/a
Current: $0.28
Upside: -
RedHill Biopharma
Oct 6, 2017
Initiates: Buy
Price Target: n/a
Current: $0.36
Upside: -